Appendix 5

2012 Reviewer Relationships With Industry and Other Entities (Relevant)—2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Peer ReviewerRepresentationEmploymentConsultantSpeaker's BureauOwnership/ Partnership/ PrincipalPersonal ResearchInstitutional, Organizational, or Other Financial BenefitExpert Witness
Sana Al-KhatibOfficial Representative—AHADuke Clinical Research Institute and Duke University Medical CenterNone
  • Medtronic

NoneNoneNoneNone
Hugh CalkinsOfficial Representative—HRSJohns Hopkins Hospital
  • Biosense Webster

  • Boston Scientific

  • Medtronic

NoneNone
  • Boston Scientific

  • Medtronic

  • St. Jude Medical

NoneNone
James R. EdgertonOfficial Representative—STSThe Heart Hospital Baylor PlanoNoneNoneNoneNoneNoneNone
Michael M. GivertzOfficial Representative—HFSABrigham and Women's HospitalNoneNoneNoneNoneNoneNone
Jonathan L. HalperinOfficial Representative—ACCF/AHA Task Force on Practice Guidelines Lead ReviewerMount Sinai Medical Center
  • Biotronik

NoneNoneNoneNoneNone
Bradley P. KnightOfficial Representative—HRSNorthwestern Medical Center
  • Boston Scientific

  • Cameron Health

  • Biosense Webster

  • Biotronik

  • Boston Scientific

  • Medtronic

None
  • Cameron Health

NoneNone
Thomas J. LewandowskiOfficial Representative—ACCF Board of GovernorsAppleton Cardiology ThedacareNoneNoneNoneNoneNoneNone
Henry M. SpotnitzOfficial Representative—AATSColumbia UniversityNoneNone
  • Strategic Pacing Systems

NoneNoneNone
C. Michael ValentineOfficial Representative—ACCF Board of TrusteesThe Cardiovascular Group
  • Medtronic

NoneNoneNoneNoneNone
Paul J. WangOfficial Representative—AHAStanford University Medical Center
  • Medtronic

NoneNone
  • Medtronic

NoneNone
John F. BeshaiContent Reviewer—ACCF EP CommitteeUniversity of Chicago Medical CenterNoneNoneNoneNone
  • Medtronic

  • St. Jude Medical

None
George H. CrossleyContent ReviewerSt. Thomas Heart
  • Boston Scientific

  • Medtronic

  • Boston Scientific

  • Medtronic

NoneNone
  • Boston Scientific

  • Medtronic

None
Jennifer E. CummingsContent Reviewer—ACCF EP CommitteeUniversity of ToledoNone
  • Boston Scientific

  • Medtronic

  • St. Jude

NoneNoneNoneNone
Kenneth A. EllenbogenContent ReviewerVirginia Commonwealth University Medical Center
  • Cameron Health

  • Boston Scientific

  • Medtronic

  • Biotronik

  • Boston Scientific

  • Medtronic

  • St. Jude Medical

NoneNone
  • Biosense Webster

  • Boston Scientific

  • Medtronic

  • St. Jude Medical

None
Roger A. FreedmanContent ReviewerUniversity of Utah Health Sciences Center
  • Boston Scientific

  • Sorin

  • Spectranetics

  • St. Jude Medical

NoneNone
  • Medtronic

  • St. Jude Medical

None
  • Defendant, 2011, pacemaker battery depletion

Gabriel GregoratosContent ReviewerUniversity of California–San FranciscoNoneNoneNoneNoneNoneNone
David L. HayesContent ReviewerMayo Clinic
  • Biotronik

  • Boston Scientific

  • Medtronic

  • Sorin

  • St. Jude Medical

NoneNoneNoneNoneNone
Mark A. HlatkyContent ReviewerStanford University School of MedicineNoneNoneNoneNoneNoneNone
Sandeep K. JainContent ReviewerUniversity of Pittsburgh Physicians, UPMC Heart and Vascular InstituteNoneNoneNone
  • Medtronic

NoneNone
Samuel O. JonesContent ReviewerSan Antonio Military Medical CenterNoneNoneNoneNone
  • Medtronic

  • St. Jude Medical

None
Kousik KrishnanContent ReviewerRush University Medical Center
  • Boston Scientific

  • St. Jude Medical

NoneNoneNone
  • Biotronik

  • Boston Scientific—Multicenter MADIT-RIT study

  • Medtronic

None
Michael MansourContent ReviewerCardiovascular PhysiciansNoneNoneNoneNoneNoneNone
Steven M. MarkowitzContent Reviewer—ACCF EP CommitteeNew York Hospital
  • Biotronik

  • Boston Scientific

  • Medtronic

  • St. Jude Medical

NoneNoneNone
  • Biosense Webster

  • Boston Scientific

  • Medtronic

  • St. Jude Medical

None
Marco A. MercaderContent ReviewerGeorge Washington UniversityNoneNoneNoneNone•NoneNone
Simone MuscoContent ReviewerSaint Patrick Hospital
  • Boston Scientific

NoneNoneNoneNoneNone
L. Kristin NewbyContent ReviewerDuke University Medical CenterNoneNoneNoneNoneNoneNone
Brian OlshanskyContent Reviewer—ACCF EP CommitteeUniversity of Iowa Hospitals
  • Boston Scientific–Guidant

  • Medtronic

NoneNoneNoneNoneNone
Richard L. PageContent ReviewerUniversity of Wisconsin Hospital and ClinicsNoneNoneNoneNoneNoneNone
Allen J. SolomonContent ReviewerMedical Faculty AssociatesNoneNoneNoneNoneNoneNone
John S. StrobelContent ReviewerInternal Medicine AssociatesNoneNoneNone
  • Medtronic

NoneNone
Stephen L. WintersContent ReviewerMorristown Medical Center
  • Biosense Webster

NoneNoneNone
  • Boston Scientific

  • Medtronic

  • St. Jude Medical

  • Defendant, 2011, complication of ICD placement

This table represents the relationships of reviewers with industry and other entities that were disclosed at the time of peer review and determined to be relevant. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or if the interest represents ownership of ≥$10,000 of the fair market value of the business entity, or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Names are listed in alphabetical order within each category of review.

According to the ACCF/AHA, a person has a relevant relationship IF: (a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or (b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document or makes a competing drug or device addressed in the document; or (c) the person or a member of the person's household has a reasonable potential for financial, professional, or other personal gain or loss as a result of the issues or content addressed in the document.

AATS indicates American Association for Thoracic Surgery; ACCF, American College of Cardiology Foundation; AHA, American Heart Association; EP, Emergency Physicians; HFSA, Heart Failure Society of America; HRS, Heart Rhythm Society; ICD, implantable cardioverter-defibrillator; MADIT-RIT, Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy; and STS, Society of Thoracic Surgeons.

  • Significant relationship.

  • No financial benefit.